glp 1 drugs and parkinson's disease Are we measuring the wrong primary outcome for GLP-1 for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep Ozempic and other GLP-1 drugs

By influencing NAD-related pathways, it provides researchers with a focused tool for investigating cellular energy balance, metabolic regulation, and molecular signaling in controlled laboratory environments

Every day, about 1% of your oldest red blood cells are destroyed and replaced

Several developments could significantly advance understanding of this compound in the coming years

An alternate version called Rybelsus was approved in September 2019, also as a Type 2 diabetes treatment, and semaglutide received approval for weight loss in June 2021 under the brand name Wegovy

CONTACT: Jami Goldstein (614) 221-8492 [email protected]

These peptides help with weight loss and support the bodys ability to maintain optimal energy levels, which can improve workout performance and recovery